Home › Compare › HUGE vs MRK

HUGE vs MRK: Dividend Comparison 2026

HUGE yields 2224.69% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HUGE wins by $26886357809.28M in total portfolio value
10 years
HUGE
HUGE
● Live price
2224.69%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26886357809.31M
Annual income
$24,702,111,776,993,104.00
Full HUGE calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — HUGE vs MRK

📍 HUGE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHUGEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HUGE + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
HUGE pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUGE
Annual income on $10K today (after 15% tax)
$189,099.00/yr
After 10yr DRIP, annual income (after tax)
$20,996,795,010,444,136.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, HUGE beats the other by $20,996,795,010,443,330.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUGE + MRK for your $10,000?

HUGE: 50%MRK: 50%
100% MRK50/50100% HUGE
Portfolio after 10yr
$13443178904.67M
Annual income
$12,351,055,888,497,028.00/yr
Blended yield
91.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HUGE
No analyst data
Altman Z
-16.8
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUGE buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHUGEMRK
Forward yield2224.69% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$26886357809.31M ✓$30.7K
Annual income after 10y$24,702,111,776,993,104.00 ✓$950.29
Total dividends collected$26732540812.68M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HUGE vs MRK ($10,000, DRIP)

YearHUGE PortfolioHUGE Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$233,169$222,469.41$11,192$351.54+$222.0K → HUGE
2$5,097,441$4,847,949.65$12,524$392.70+$5.08M → HUGE
3$104,504,369$99,050,107.14$14,015$438.65+$104.49M → HUGE
4$2,009,632,678$1,897,813,002.91$15,682$489.96+$2009.62M → HUGE
5$36,257,963,200$34,107,656,235.06$17,547$547.23+$36257.95M → HUGE
6$613,911,185,428$575,115,164,804.17$19,632$611.16+$613911.17M → HUGE
7$9,757,551,142,472$9,100,666,174,063.52$21,963$682.53+$9757551.12M → HUGE
8$145,624,394,080,622$135,183,814,358,176.64$24,571$762.18+$145624394.06M → HUGE
9$2,041,351,432,070,910$1,885,533,330,404,645.00$27,486$851.08+$2041351432.04M → HUGE
10$26,886,357,809,308,976$24,702,111,776,993,104.00$30,745$950.29+$26886357809.28M → HUGE

HUGE vs MRK: Complete Analysis 2026

HUGE — Stock

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.

Full HUGE Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this HUGE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUGE vs SCHDHUGE vs JEPIHUGE vs OHUGE vs KOHUGE vs MAINHUGE vs JNJHUGE vs ABBVHUGE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.